Curebase

Executive Summary

Curebase is an AI-native eClinical technology company that offers a unified software platform for clinical trials, integrating ePRO, eConsent, EDC, patient recruitment, and site management. By streamlining trial operations and leveraging artificial intelligence, Curebase aims to accelerate study timelines, improve data quality, and enhance patient engagement for sponsors, CROs, and research sites. Founded in 2017 and headquartered in San Francisco, the company operates in the rapidly growing digital health sector, where demand for decentralized and technology-enabled trials is rising. Although Curebase is private and has not disclosed funding details, its integrated approach positions it as a competitive player in the eClinical space, addressing key pain points in clinical research. The company's focus on AI-driven solutions differentiates it from traditional vendors, potentially driving adoption as the industry shifts toward more efficient, patient-centric trial designs.

Upcoming Catalysts (preview)

• Q3 2026Strategic Partnership with a Top 20 Pharma60% success
• Q2 2026Launch of AI-Powered Site Matching or Patient Recruitment Module70% success
• Q4 2026Series C Funding Round Announced50% success